Avanir Pharmaceuticals Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (16)

Latest Posts

About This Stock More About This Stock
Big Upcoming Catalysts For These 2 Small Biotechs
Article By: Bret Jensen
Wednesday, April 29, 2015 3:36 AM EDT
Protalix has a market capitalization of around $200 million, one fast growing approved product, and four other compounds in early development and the shares seem worthy of a small, speculative investment given upcoming catalysts.
In this article: AVNR, GSK, AGEN, MRK, PLX, INCY, PFE
Read
Buy These 3 Small Cap Rockets With Big Potential
Article By: Bret Jensen
Tuesday, March 31, 2015 10:32 PM EDT
Small cap stocks tend to have sharper swings, both up and down. It is very important to have a well-diversified portfolio of promising small cap stocks within one’s portfolio to mitigate volatility.
In this article: AVNR, EGRX, GLDD, CNAT, SGYP
Read
When Big Pharma Comes A-Calling: 3 Likely Takeover Targets For 2015
Article By: Bret Jensen
Monday, February 23, 2015 5:14 AM EDT
The small biotech and biopharma sectors has been very kind to my portfolio over the past six months.
In this article: AVNR, EGRX, TEVA, AGEN, INCY, GSK, HALO, BAX, JNJ, PFE
Read
2 More Triple Digit Winners In Biotech
Article By: Bret Jensen
Monday, February 16, 2015 5:43 AM EDT
The small cap biotech and biopharma complex has been very kind to everyone. Here are two more recommendations that have the signature Bret Jensen “X” factors that make up a great small cap biotech investment.
In this article: THLD, MSTX, AVNR, CRIS, ZIOP
Read
EC Our 3 Potential Triple Digit Biotech Winners Revisited
Article By: Bret Jensen
Tuesday, February 10, 2015 2:29 PM EDT
We’ve enjoyed a lot of success with biotechs lately, most notably Avanir that got bought out and gave Small Cap Gems subscribers a profit of 214.7% in only five months.
In this article: NAVB, INCY, AGEN, CRIS, AVNR
Read

PARTNER HEADLINES

Latest Tweets for $AVNR

No tweets yet!